Asphyxia
14
2
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
88.9%
+2.3% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Multimodal Analysis of Early Biomarkers of the Impacts of Perinatal Asphyxia
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
Resuscitation Table Height for Face-mask Ventilation in Infants
Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns
AI to Improve Data From Danish Cardiac Arrest Registry
The MAMAACT Intervention
BiHiVE2 Study. The Investigation and Validation of Predictive Biomarkers in Hypoxic-ischaemic Encephalopathy.
Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana
New Prophylactic Maneuver: the "Pushing" Maneuver, Aiming to Reduce the Risk for Shoulder Dystocia
Evaluation of Lactate Dehydrogenase as Decision Support for Admissions to Neonatal Ward
Resuscitation of Late-preterm Infants by Using Room Air or 100% Oxygen
BRAIN - Home Intervention Trial
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth